Needham & Company LLC Reaffirms Buy Rating for Quantinuum (NASDAQ:QNT)

Quantinuum (NASDAQ:QNT)‘s stock had its “buy” rating reissued by analysts at Needham & Company LLC in a report released on Wednesday,Benzinga reports. They currently have a $100.00 price objective on the stock. Needham & Company LLC’s target price indicates a potential upside of 78.38% from the stock’s previous close.

Other research analysts have also recently issued research reports about the company. Zacks Research raised Quantinuum to a “hold” rating in a research note on Tuesday, June 30th. UBS Group began coverage on shares of Quantinuum in a research report on Monday, June 29th. They set a “buy” rating and a $93.00 price target on the stock. Jefferies Financial Group set a $85.00 target price on shares of Quantinuum in a report on Wednesday. TD Cowen assumed coverage on Quantinuum in a report on Monday, June 29th. They issued a “buy” rating on the stock. Finally, Mizuho assumed coverage on Quantinuum in a research note on Monday, June 29th. They set an “outperform” rating and a $90.00 price objective for the company. Twelve analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $98.33.

Quantinuum Price Performance

Shares of NASDAQ:QNT opened at $56.06 on Wednesday. The company’s 50 day moving average price is $62.71. Quantinuum has a 12 month low of $47.06 and a 12 month high of $86.79.

Quantinuum (NASDAQ:QNT) last announced its earnings results on Tuesday, August 11th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.02). The business had revenue of $8.00 million during the quarter. As a group, equities research analysts anticipate that Quantinuum will post -1.61 earnings per share for the current year.

Insider Activity

In related news, Director Paul R. Daugherty bought 4,000 shares of the business’s stock in a transaction dated Friday, June 5th. The shares were purchased at an average price of $60.00 per share, with a total value of $240,000.00. Following the purchase, the director owned 9,833 shares of the company’s stock, valued at approximately $589,980. This trade represents a 68.58% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Kenneth D. Denman purchased 14,000 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The stock was bought at an average cost of $60.00 per share, with a total value of $840,000.00. Following the completion of the purchase, the director owned 19,833 shares of the company’s stock, valued at $1,189,980. This represents a 240.01% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders have purchased 411,032 shares of company stock worth $24,661,920.

Institutional Investors Weigh In On Quantinuum

A hedge fund recently bought a new position in Quantinuum stock. Lisanti Capital Growth LLC purchased a new position in Quantinuum Inc. (NASDAQ:QNT) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 5,005 shares of the company’s stock, valued at approximately $409,000.

Key Headlines Impacting Quantinuum

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Quantinuum reported second-quarter revenue of $8 million, a 279% year-over-year increase, and raised its fiscal 2026 revenue outlook to $28 million-$32 million versus the $26.6 million analyst consensus. Quantinuum Reports Second Quarter 2026 Results
• Positive Sentiment: Quantinuum announced a multiyear partnership with Oracle (NYSE: ORCL) to deploy its 98-qubit Helios system in a U.S.-based Oracle Cloud Infrastructure AI data center. Customers will be able to access hybrid quantum-AI and high-performance computing capabilities through Oracle Cloud without owning specialized quantum hardware, potentially accelerating commercial adoption. Oracle, Quantinuum partner to bring quantum computing to cloud
• Positive Sentiment: The company said Helios demonstrated near five-nines logical fidelity, reinforcing Quantinuum’s positioning in fault-tolerant quantum computing. The Oracle deployment could provide an important bridge from technical milestones to applications such as drug discovery, materials science, financial modeling and optimization. Quantinuum Puts a 98-Qubit Helios Machine Inside Oracle’s AI Data Centers
• Negative Sentiment: Quantinuum reported an adjusted loss of $0.28 per share, slightly worse than the $0.26 consensus estimate. The earnings shortfall and the company’s still-small revenue base appear to have outweighed the favorable outlook and strategic partnership, helping explain why the stock finished lower. Quantinuum Reports Second Quarter 2026 Results

Quantinuum Company Profile

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.